Susquehanna International Group
NAGE

Susquehanna International Group’s Niagen Bioscience NAGE Stock Holding History

Susquehanna International Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.7K Buy
+15,800
New +$85.3K ﹤0.01% 12512
2025
Q4 		– Sell
-24,700
Closed -$230K – 14021
2025
Q3 		$230K Sell
24,700
-49,500
-67% -$500K ﹤0.01% 10681
2025
Q2 		$1.07M Buy
+74,200
New +$733K ﹤0.01% 7242
2025
Q1 		– Sell
-18,100
Closed -$96.1K – 13700
2024
Q4 		$96.1K Buy
+18,100
New +$99.1K ﹤0.01% 11372
2024
Q3 		– Sell
-12,800
Closed -$34.9K – 13261
2024
Q2 		$34.9K Buy
12,800
+1,500
+13% +$5.02K ﹤0.01% 11528
2024
Q1 		$39.3K Buy
+11,300
New +$20.9K ﹤0.01% 11638
2022
Q2 		– Sell
-10,300
Closed -$25K – 14145
2022
Q1 		$25K Sell
10,300
-5,500
-35% -$15K ﹤0.01% 12567
2021
Q4 		$59K Sell
15,800
-11,700
-43% -$63.2K ﹤0.01% 12463
2021
Q3 		$172K Sell
27,500
-10,200
-27% -$84.1K ﹤0.01% 11653
2021
Q2 		$372K Sell
37,700
-261,000
-87% -$2.28M ﹤0.01% 10310
2021
Q1 		$2.79M Buy
+298,700
New +$2.37M ﹤0.01% 5126
2020
Q3 		– Sell
-17,500
Closed -$80K – 11264
2020
Q2 		$80K Buy
+17,500
New +$78.3K ﹤0.01% 9596
2020
Q1 		– Sell
-11,200
Closed -$48K – 11025
2019
Q4 		$48K Sell
11,200
-4,700
-30% -$16.7K ﹤0.01% 9357
2019
Q3 		$63K Buy
15,900
+1,000
+7% +$4.26K ﹤0.01% 9717
2019
Q2 		$69K Sell
14,900
-8,400
-36% -$35.8K ﹤0.01% 9751
2019
Q1 		$98K Buy
+23,300
New +$84K ﹤0.01% 8256
2018
Q2 		– Sell
-15,200
Closed -$64K – 10571
2018
Q1 		$64K Buy
+15,200
New +$79.6K ﹤0.01% 8876
2017
Q3 		– Sell
-11,800
Closed -$45K – 9763
2017
Q2 		$45K Buy
+11,800
New +$37.4K ﹤0.01% 8913

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's NAGE Position: Q1 2026 in Review

Susquehanna International Group increased its Niagen Bioscience (NAGE) stake by 5% in Q1 2026, buying an estimated $12.5K and bringing the position to 48,672 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11551.

Susquehanna International Group first reported a position in NAGE in Q2 2016 and has held it in 30 quarters since. The position peaked at $3.28M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Susquehanna International Group held 48,672 shares of Niagen Bioscience worth $215K as of Q1 2026.
  • Susquehanna International Group bought 2,307 Niagen Bioscience shares in Q1 2026, an estimated $12.5K.
  • Niagen Bioscience made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11551 holding.
  • Susquehanna International Group first reported a position in Niagen Bioscience in Q2 2016 and has held it in 30 quarters since.
  • Susquehanna International Group's Niagen Bioscience position peaked at $3.28M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.